Community health workers aim to close vaccine gap for chronically ill
NCT ID NCT06156254
First seen Jun 24, 2026 · Last updated Aug 20, 2026 · Updated 3 times
Summary
This study tests whether community health workers can help adults with chronic illnesses get up-to-date on COVID-19 and flu vaccines. Participants receive up to three counseling sessions in English or Spanish to address their vaccine concerns. The goal is to reduce health disparities and increase vaccination rates in underserved communities.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Community health worker intervention (psychoeducational sessions and motivational interviewing)
- What this could lead to
- If successful, this approach could increase vaccination rates among vulnerable populations, reducing severe illness and hospitalizations.
- What could go wrong
- This is a behavioral study, not a drug trial, so results depend on participant engagement and may not apply broadly. The study is still recruiting and outcomes are based on self-report and records.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 800 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2023
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria:18 years or older AND speak English or Spanish AND have no obvious physical or cognitive impairment that would make them unable to complete the assessment (as indicated by confusion or inability to understand the questions). Exclusion Criteria: not willing to consent OR acutely sick OR have high suicide risk Eligibility criteria: Have received a COVID-19 vaccine but not received an updated COVID-19 vaccine at the time of recruitment AND self-report being told by a physician they have one of the following health conditions; high blood pressure/hypertension OR diabetes OR asthma OR overweight/obese OR a one of the following mental health condition (probable depression, probable generalized anxiety, or probable PTSD) \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bedford-Stuyvesant Family Health Center
Brooklyn, New York, 11216, United States
-
Brownsville Multi-Service Health Center
Brooklyn, New York, 11212, United States
-
Community Healthcare Network
New York, New York, 10010, United States
-
Morris Heights Health Center
The Bronx, New York, 10453, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple breath test cut asthma Flare-Ups?
- Custom knee guides put to the test in obese patients
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Five sessions to quiet trauma nightmares in bipolar disorder
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?